GGrantIndex
← Search

GBCC 2025: Genomic Data Science and Beyond with Galaxy and Bioconductor

$60,000R13FY2025HGNIH

Johns Hopkins University, Baltimore MD

Investigators

Abstract

Project Summary The GBCC2025 conference, "Genomic Data Science and Beyond with Galaxy and Bioconductor," aims to bridge the gap in integrating genomic data, tools, and communities. With the rapid advancements in genomic science generating an ever-increasing volume of data and analysis methods, there is a critical need for robust, accessible tools and collaborative platforms to facilitate data analysis and interpretation. Despite significant progress, substantial gaps remain in fostering environments where new analysis methods are readily developed, incorporated, and utilized, hindering the ability to achieve medical breakthroughs that improve human health. Galaxy’s user-friendly web platform and Bioconductor’s comprehensive suite of R-based genomic data analysis tools offer complementary strengths that, when combined, provide powerful, unified solutions for the genomic research community. This joint conference will enhance interoperability, promote innovative workflows, improve training and education, enrich documentation efforts, and ultimately accelerate discoveries in genomic science. The specific aims of the GBCC2025 conference are to: 1) Foster collaboration and innovation in genomic data science by organizing sessions that demonstrate the integration of Bioconductor tools into the Galaxy platform, enhancing interoperability and streamlining data analysis workflows; 2) Enhance training and education by offering structured training opportunities and hands-on workshops, including collaborative tutorials; and 3) Strengthen community and networking among genomic researchers by facilitating unified poster sessions and shared community networking events. By addressing the critical need for integrated genomic data, tools, and communities through these aims, the GBCC 2025 conference will enhance collaboration, improve training and education, and strengthen the genomic research community, ultimately accelerating discoveries in genomic science and contributing to medical breakthroughs that improve human health.

View original record on NIH RePORTER →